SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-17-148124
Filing Date
2017-04-28
Accepted
2017-04-28 16:07:01
Documents
4
Period of Report
2017-06-01
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A d381145ddef14a.htm DEF 14A 331359
2 GRAPHIC g381145dsp040.jpg GRAPHIC 288879
3 GRAPHIC g381145dsp041.jpg GRAPHIC 164052
4 GRAPHIC g381145g80a55.jpg GRAPHIC 52118
  Complete submission text file 0001193125-17-148124.txt   1025906
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35670 | Film No.: 17795462
SIC: 2834 Pharmaceutical Preparations